Genocea Biosciences Inc P / E
Was ist das P / E von Genocea Biosciences Inc?
P / E von Genocea Biosciences Inc ist 0.00
Was ist die Definition von P / E?
Das Terminkurs-Gewinn-Verhältnis ist das Verhältnis des Aktienkurses eines Unternehmens zum geschätzten Gewinn des Unternehmens je Aktie für die nächsten zwölf Monate.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P / E von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Genocea Biosciences Inc
Was macht Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Unternehmen mit p / e ähnlich Genocea Biosciences Inc
- Richland Resources International hat P / E von N/A
- Safeplus International hat P / E von N/A
- China Yanyuan Yuhui Natl Ed Grp hat P / E von N/A
- Acusphere hat P / E von N/A
- American Oriental Bioengineering hat P / E von N/A
- Gourmet Provisions International hat P / E von N/A
- Genocea Biosciences Inc hat P / E von 0.00
- SEL Manufacturing hat P / E von 0.00
- China Zhong Qi Hldgs hat P / E von 0.00
- MedSmart hat P / E von 0.00
- Panbela Therapeutics hat P / E von 0.00
- Epic hat P / E von 0.00
- 2574 hat P / E von 0.00